← SynDRA
PD-0166285
SynDRA canonical compound SYN0002414 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EGFR | FGFR1 | PDGFRB | PKMYT1 | SRC | WEE1 |
|---|
| Mechanism of action | SRC inhibitor |
|---|
All known targets
- SRC
- EGFR
- FGFR1
- PDGFRB
- PKMYT1
- WEE1
Mechanisms of action (all sources)
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
- FGFR1 INHIBITOR
- Fibroblast growth factor receptor 1 inhibitor
- PDGFRB INHIBITOR
- Platelet-derived growth factor receptor beta inhibitor
- SRC inhibitor
- Tyrosine-protein kinase SRC inhibitor
- PKMYT1 INHIBITOR
- WEE1 INHIBITOR
Cross-references
Synonyms
- PD-166285
- PD166285
- TCMDC-140940
- PD0166285
- CHEMBL49120
- 6-(2,6-dichlorophenyl)-2-({4-[2-(diethylamino)ethoxy]phenyl}amino)-8-methyl-7H,8H-pyrido[2,3-d]pyrimidin-7-one
- 6-(2,6-Dichlorophenyl)-2-({4-[2-(Diethylamino)ethoxy]phenyl}amino)-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One
- IFPPYSWJNWHOLQ-UHFFFAOYSA-N
- AC1NSKIX
- Kinome_3263
- SCHEMBL133914
- BDBM3096
- GTPL8183
- MolPort-044-560-325
- ZINC1486219
- BCP20228
- s8148
- AKOS032945173
- NCGC00242490-02
- NCGC00242490-01
- HY-13925
- CS-0008610
- PD 166285
- PD 0166285
- F2UH9R2JT6
- RefChem:1073669
- C26H27Cl2N5O2
- orb1300335
- SCHEMBL30250248
- EX-A4179
- KHA03989
- WZB81459
- CCG-269785
- EBC-114024
- NCGC00242490-08
- AC-35457
- BS-16163
- DA-76653
- PD0166285?
Look up PD-0166285 in the interactive SynDRA portal →